Urology · Watkinsville, GA
NPI
1174628127
Since 2006
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1150 Golden Way
Watkinsville, GA, 30677
Phone (706) 612-9401
Groups this clinician bills Medicare through
Medicare paid, 2024
$439K
14,861 services
Medicare patients, 2024
876
Average age 75
Drug cost, 2024
$865K
2,994 prescriptions
Company payments, 2025
$1,778
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Catherine Schwender was code J0585 (injection, onabotulinumtoxina, 1 unit), 7,500 times for 28 patients. In total Catherine Schwender billed 14,861 services in 101 codes, and Medicare paid $439K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-08-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 7,500 | 28 | $4.76 | $36K |
| 81001 Clinical Chemistry | Office | 714 | 401 | $3.09 | $2,208 |
| 81003 Clinical Chemistry | Office | 710 | 440 | $2.18 | $1,550 |
| 99214 Office E&M - Established | Office | 703 | 419 | $88.17 | $62K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 612 | 420 | $12.19 | $7,463 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 442 | 100 | $33.63 | $15K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 406 | 110 | $44.37 | $18K |
| 99213 Office E&M - Established | Office | 406 | 358 | $57.22 | $23K |
| 51798 Ultrasound - Nonspecific | Office | 337 | 251 | $7.07 | $2,383 |
| 52000 Cystourethroscopy | Office | 167 | 140 | $156.04 | $26K |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 153 | 140 | $38.02 | $5,817 |
| 99232 Hospital E&M - Subsequent | Facility | 140 | 91 | $59.16 | $8,282 |
| 99204 Office E&M - New | Office | 112 | 112 | $105.86 | $12K |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 112 | 82 | $46.16 | $5,170 |
| 74019 Standard X-ray | Office | 74 | 68 | $21.26 | $1,573 |
By year: 2022 $308K for 9,772 services; 2023 $403K for 10,758 services; 2024 $439K for 14,861 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81001 Clinical Chemistry | 714 | 401 | $3.09 | $2,208 |
| 81003 Clinical Chemistry | 710 | 440 | $2.18 | $1,550 |
Medicare prescription drug claims, 2024
In 2024, the drug Catherine Schwender prescribed most often to Medicare patients was Myrbetriq (Mirabegron), with 282 prescriptions and refills. In total Catherine Schwender wrote 2,994 Medicare prescriptions that cost $865K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Myrbetriq Mirabegron | 282 | 465 | 88 | $214K |
| Gemtesa Vibegron | 209 | 310 | 59 | $151K |
| Methenamine Hippurate Generic | 196 | 444 | 76 | $13K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 196 | 450 | 87 | $3,520 |
| Tamsulosin Hcl Generic | 193 | 512 | 90 | $2,766 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 176 | 217 | 109 | $3,625 |
| Estradiol Generic | 162 | 418 | 95 | $15K |
| Solifenacin Succinate Generic | 107 | 217 | 41 | $3,857 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 105 | 105 | 96 | $638 |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 101 | 147 | 52 | $2,900 |
| Cephalexin Generic | 99 | 131 | 38 | $1,021 |
| Finasteride Generic | 88 | 244 | 36 | $876 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 71 | 78 | 49 | $426 |
| Ondansetron Hcl Generic | 71 | 71 | 61 | $276 |
| Ondansetron Odt Ondansetron | 68 | 68 | 63 | $573 |
Brand drugs: - claims; generic drugs: 2,378 claims; opioid claims: 154.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Catherine Schwender $1,778 ($1,778 in general payments such as food, travel and fees) from 15 companies. The largest payer was Teleflex LLC with $773.
| Company | Payments | Amount |
|---|---|---|
| Teleflex LLC TFX | 2 | $773 |
| Ferring Pharmaceuticals Inc. | 5 | $227 |
| Medtronic, Inc. MDT | 2 | $166 |
| Astellas Pharma US Inc 4503.T | 3 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $140 |
| Laborie Medical Technologies Corp. | 3 | $74.29 |
| Abbvie Inc. ABBV | 2 | $54.77 |
| Escala Medical Inc. | 1 | $37.53 |
| Boston Scientific Corporation BSX | 2 | $32.43 |
| Verity Pharmaceuticals Inc. | 2 | $28.83 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.